Accessibility statement

Marta Soares



Marta Soares joined the Team for Economic Evaluation and Health Technology Assessment (TEEHTA) in 2009. She holds an MSc in Biostatistics awarded by the University of Lisbon in 2008 and a PhD on “Making best use of evidence for explicit decisions in health care” awarded by the University of York in 2017.

Marta's research interests are related to the development and application of statistical, econometric and decision analysis methods in all components of health technology assessment, including statistical analysis of primary data, evidence synthesis, elicitation of expert opinion, decision modelling methods and value of further research analysis. 

Marta served as a member of the National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee between 2011 and 2017 and since 2017 she acts as a pharmacoeconomic expert for INFARMED in Portugal. In 2020, Marta joined the General HTA Programme Funding Committee.

In 2014, Marta won the ISPOR Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research. The award was given for the research paper: Methods to assess cost-effectiveness and value of further research when data are sparse: Negative-pressure wound therapy for severe pressure ulcers. Med Decis Making April 1 2013;33(3):415-436. Details of the paper can be downloaded from here



  • The development and application of statistical, econometric and decision analysis methods in all components of health technology assessment and value of further research analysis. 


  • Methods for estimation of the NICE cost-effectiveness threshold Methodological research
  • NICE STA: Fingolimod for the treatment of relapsing-remitting multiple sclerosis
  • The  clinical and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision analytical model
  • Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
  • VenUS IV (Venous leg Ulcer Study IV): A randomised controlled trial of compression hosiery versus compression bandaging in the treatment of venous leg ulcers
  • Economic evaluation for the global excellence in COPD outcomes (GECo) study

Recently completed projects

  • NICE STA: Capecitabine for the treatment of advanced gastric cancer
  • NICE STA: Bevacuzimab in combination with taxanes for the treatment of HER2-negative 1st line metastatic breast cancer
  • An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock) 
  • VAC therapy for pressure ulcers: value of information analysis and feasibility study

Research group(s)

Staff Photo for Marta Soares

Contact details

Marta Soares
Centre for Health Economics